ArticleAngewandte Chemie (International ed. in English)2026
Dual-Channel Interdigitated Aptamer-Based Sensors for Rapid Small-Molecule Detection in Biofluids.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Selective and Fast Cortisol Sensing in Human Saliva Using Graphene-Based On-Chip Field-Effect Transistors.Small science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Timely and decentralized quantification of small-molecule biomarkers is essential for point-of-care (POC) diagnostics, but their reliable detection in biofluids remains challenging. Here, we introduce an engineered electrochemical aptamer sensing platform that employs a dual-channel signal conversion strategy to overcome these limitations. By integrating spatially separated interdigitated working electrodes with selective self-assembled monolayer (SAM) removal, the system enables target-induced release and recapture of methylene blue-labeled complementary DNA (MB-cDNA) probes across two electrodes. This configuration minimizes background interference and enhances mass transport, facilitating robust dual-channel signal transduction. The platform enables rapid (≤ 30 min), low-volume (30 µL) detection of prototypical small molecules, dopamine and cortisol, in diverse biofluids, including artificial cerebrospinal fluid (aCSF), human serum, and saliva. Notably, the signal conversion mechanism remained effective across different targets and sample types, requiring only minimal adaptation of the recognition sequence. Together, these features establish a versatile electrochemical sensing architecture with broad potential for rapid, quantitative small-molecule analysis in complex biological media.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.